SCHEMBL2442872

SCHEMBL2442872

O=C(O)c1ccccc1C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
ALOX15 P16050 2/20 0.52
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA4 P22748 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HMGB1 P09429 1/20 0.45
HPGD P15428 1/20 0.45
CA6 P23280 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MAPT P10636 2/20 0.43
HDAC8 Q9BY41 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9987053 0.84 BCAT2 (0.46) ALDH1A1ALOX15KDM4EHPGDMAPT
SCHEMBL538689 0.83 ALDH1A1 (0.52) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL989424 0.83 USP2 (0.50) ALDH1A1CA1CA2SMN1; SMN2MAPT
SCHEMBL28645883 0.83 ALDH1A1 (0.56) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL11044633 0.80 ALDH1A1 (0.59) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL9327758 0.80 CYP2C9 (0.55) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL11591149 0.79 CRHBP (0.53) ALDH1A1ALOX15HPGDMAPTCRHBP
SCHEMBL31186401 0.78 ALDH1A1 (0.62) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL8402762 0.78 ALDH1A1 (0.62) ALDH1A1ALOX15CA12CA1CA2
SCHEMBL30090914 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572795-A2 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS The University of Chicago (US) 2025-06-25 EP disclosed
WO-2024040169-A2 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS THE UNIVERSITY OF CHICAGO (US) 2024-02-22 WO disclosed
EP-4126063-A1 BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF Flagship Pioneering, Inc. (US) 2023-02-08 EP disclosed
EP-3976061-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-TARGETED ADJUVANTS The University of Chicago (US) 2022-04-06 EP disclosed
WO-2021195295-A1 BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF FLAGSHIP PIONEERING, INC. (US) 2021-09-30 WO disclosed
WO-2020247973-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-TARGETED ADJUVANTS THE UNIVERSITY OF CHICAGO (US) 2020-12-10 WO disclosed
EP-3356371-A1 POLYMER CONJUGATE VACCINES The University of Chicago (US) 2018-08-08 EP disclosed
EP-2983698-A1 NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS Clinique La Prairie (CH) 2016-02-17 EP disclosed
WO-2014167091-A1 NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS CLINIQUE LA PRAIRIE (CH) 2014-10-16 WO disclosed
EP-2367848-A1 USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2011-09-28 EP disclosed
WO-2010015421-A1 USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin (DE) 2010-02-11 WO disclosed
EP-1485707-A4 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS INC (US) 2005-11-16 EP disclosed
EP-1485707-A2 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK Pharmaceuticals, Inc. (US) 2004-12-15 EP disclosed
WO-2003092581-A9 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS INC (US) 2004-02-19 WO disclosed
WO-2003092581-A2 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS, INC. (US) 2003-11-13 WO disclosed